Pro-inflammatory and proliferative signaling proteins

Pro-inflammatory and proliferative signaling proteins is a broad functional category encompassing various molecular entities that regulate immune responses and cellular growth. This group includes secreted cytokines like Tumor Necrosis Factor (TNF) and Interleukin-1 (IL-1), as well as growth factors such as Epidermal Growth Factor (EGF) and Vascular Endothelial Growth Factor (VEGF) (Source: NIH, StatPearls). These proteins initiate complex intracellular cascades, most notably the JAK/STAT, MAPK/ERK, and PI3K/AKT pathways, which ultimately modulate gene expression to drive inflammation or cell division (Source: Nature Reviews Molecular Cell Biology). In pathological states like cancer and autoimmune disorders, these signaling pathways are often hyperactivated, leading to chronic tissue damage or malignant transformation (Source: PubMed). Therapeutic agents targeting these proteins include monoclonal antibodies that neutralize ligands and small molecule inhibitors that block kinase activity (Source: PubChem). However, because these signaling pathways are integral to normal physiology, their inhibition can lead to significant safety concerns, including immunosuppression and impaired tissue repair (Source: FDA). This term is generally considered too broad to serve as a specific therapeutic target in a structured database.

Other names

Inflammatory mediatorsMitogenic signaling moleculesPro-inflammatory cytokinesGrowth signaling proteinsPro-inflammatory and proliferative signaling pathways

Inhibition of signaling cascades through ligand neutralization, receptor antagonism, or intracellular kinase inhibition (Source: PubChem).